Medtechs Ready To Take Creative Approach To Deal-Making With An Eye On Start-Ups

Ground-breaking M&A deals were largely absent from medtech industry schedules in 2018 – Boston’s BTG deal aside – but that does not mean consolidation of the medtech industry is slowing down. M&A deal numbers have been steady of late, even if aggregate deal value has declined in recent years. Digital transformation is a catalyst for a growing number of sector-transforming transactions.

More from Deal-Making

More from In Vivo